These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 1828531

  • 1. Ondansetron to prevent vomiting after cancer chemotherapy.
    Med Lett Drugs Ther; 1991 Jun 28; 33(847):63-4. PubMed ID: 1828531
    [No Abstract] [Full Text] [Related]

  • 2. Ondansetron to prevent chemotherapy-induced vomiting.
    Drug Ther Bull; 1992 Mar 16; 30(6):21-3. PubMed ID: 1534293
    [No Abstract] [Full Text] [Related]

  • 3. Preliminary experience with use of a selective 5HT3 receptor antagonist (ondansetron) to prevent high dose chemotherapy induced emesis.
    Parikh PM, Shah SR, Shah SC, Sheth V, Patel RA, Shah KC, Jain PK.
    Indian J Cancer; 1996 Mar 16; 33(1):17-20. PubMed ID: 9063013
    [Abstract] [Full Text] [Related]

  • 4. [Serotonin as mediator in vomiting reflex: effect of a serotonin3 receptor antagonist in chemotherapy-induced vomiting].
    Layer P.
    Z Gastroenterol; 1991 May 16; 29(5):265-6. PubMed ID: 1835227
    [No Abstract] [Full Text] [Related]

  • 5. Fighting nausea in the '90s: more and better anti-emetics can help.
    Saphir A.
    J Natl Cancer Inst; 1997 Sep 03; 89(17):1252-5. PubMed ID: 9293911
    [No Abstract] [Full Text] [Related]

  • 6. Management of chemotherapy-related nausea and vomiting using a serotonin antagonist.
    Egan AP, Taggart JR, Bender CM.
    Oncol Nurs Forum; 1992 Jun 03; 19(5):791-5. PubMed ID: 1535124
    [Abstract] [Full Text] [Related]

  • 7. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
    Sorbe BG.
    Semin Oncol; 1994 Oct 03; 21(5 Suppl 9):20-6. PubMed ID: 9113123
    [Abstract] [Full Text] [Related]

  • 8. Drugs for vomiting caused by cancer chemotherapy.
    Med Lett Drugs Ther; 1993 Dec 24; 35(912):124-6. PubMed ID: 8264505
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Making chemotherapy easier.
    Grunberg SM.
    N Engl J Med; 1990 Mar 22; 322(12):846-8. PubMed ID: 2137903
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. 5-hydroxytryptamine-3 receptor antagonist with or without short-course dexamethasone in the prophylaxis of radiation induced emesis: a placebo-controlled randomized trial of the National Cancer Institute of Canada Clinical Trials Group (SC19).
    National Cancer Institute of Canada Clinical Trials Group (SC19)National Cancer Institute of Canada Clinical Trials Group, Canada. Rebecca.wong@rmp.uhn.on.ca, Wong RK, Paul N, Ding K, Whitehead M, Brundage M, Fyles A, Wilke D, Nabid A, Fortin A, Wilson D, McKenzie M, Ackerman I, Souhami L, Chabot P, Pater J.
    J Clin Oncol; 2006 Jul 20; 24(21):3458-64. PubMed ID: 16849762
    [Abstract] [Full Text] [Related]

  • 19. Safety and efficacy of a continuous infusion, patient-controlled antiemetic pump for children receiving emetogenic chemotherapy.
    Jones E, Koyama T, Ho RH, Kuttesch J, Shankar S, Whitlock JA, Cartwright J, Frangoul H.
    Pediatr Blood Cancer; 2007 Mar 20; 48(3):330-2. PubMed ID: 16304666
    [Abstract] [Full Text] [Related]

  • 20. Development of serotonin antagonists for the control of chemotherapy-induced emesis.
    Hainsworth JD.
    Semin Surg Oncol; 1993 Mar 20; 9(3):279-84. PubMed ID: 8516617
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.